YinQiSanHuang Jiedu decoction for the treatment of hepatitis B-related compensated liver cirrhosis: study protocol for a multi-center randomized controlled trial

INTRODUCTION: Hepatitis B-related compensated liver cirrhosis is related to a higher risk of hepatocellular carcinoma, and antiviral therapy is the preferred method. As the pathological mechanisms of liver fibrosis are complex, drugs developed for a single target are difficult to be effective in cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qing-Juan, Lv, Wen-Liang, Li, Juan-Mei, Zhang, Ting-Ting, Zhou, Wen-Hui, Zhang, Qiang, Wang, Jiu-Chong, Wang, Qing-Nan, Yao, Zi-Ang, Qiang, Rui, Chen, Si-Tong, Zhao, Xin, Liu, Shuang, Cao, Zheng-Min, Xu, Lei, Li, Gao-Hui, Chen, Jing, Wang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515328/
https://www.ncbi.nlm.nih.gov/pubmed/34649610
http://dx.doi.org/10.1186/s13063-021-05650-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515328/
https://www.ncbi.nlm.nih.gov/pubmed/34649610
http://dx.doi.org/10.1186/s13063-021-05650-6

Ejemplares similares